胃がんにおける有望な治療標的としてのクラウジン18.2
Agata Poniewierska-Baran1,2, Paulina Plewa2, Zuzanna Żabicka1
1Institute of Biology, University of Szczecin, Felczaka 3c, 71-412 Szczecin, Poland.
Cells
|August 27, 2025
まとめ
胃がん (GC) 治療の有望な標的である. 標的型薬剤と免疫療法は臨床試験で高い有効性と安全性を示し,GC患者にとって新しい希望をもたらしています.
科学分野:
- 腫瘍学
- 分子生物学
- 胃腸内科
背景:
- クラウジン-18. 2 (CLDN18. 2) は,胃の恒常性にとって重要な緊密結合タンパク質である.
- CLDN18.2の発現は胃に限定され,胃がん (GC) の特定のバイオマーカーとなっています.
研究 の 目的:
- GCにおけるバイオマーカーとしてのCLDN18.2の役割を検討する.
- CLDN18.2を標的とする治療法とその臨床応用について議論する.
主な方法:
- 既存の文献と臨床試験のデータを記述したレビュー.
- CLDN18. 2標的薬剤に対する臨床前および臨床的証拠の分析
主要な成果:
- モノクローナル抗体 (mAB) とCAR- T細胞免疫療法を含むCLDN18. 2を標的とする治療は,有意な可能性を示しています.
- 世界中で進行中の臨床試験では,これらの新しいGC治療法が評価されています.
結論:
- CLDN18. 2は胃がんの有効な治療標的である.
- CLDN18. 2に対する標的治療は,有望な有効性と安全性プロファイルを示し,GC治療戦略を進めている.
さらに関連する動画
09:24Combined Conditional Knockdown and Adapted Sphere Formation Assay to Study a Stemness-Associated Gene of Patient-derived Gastric Cancer Stem Cells
Published on: May 9, 2020
4.5K
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
1.6K
関連する概念動画
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Mucosal Barrier of the Stomach
833
The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl.
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
833
Gastritis-II: Pathophysiology
543
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
543
What is Monogastric Digestion?
72.5K
The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
72.5K
